Neuroendocrine carcinoma of tonsil presented with axillary lymph node metastasis: Management dilemma

被引:0
|
作者
Kamarudin, Zalikha [1 ]
Jamaluddin, Nadia [1 ]
Latar, Nani Harlina Md [1 ]
Pauzi, Suria Hayati Md [2 ]
Muhammad, Rohaizak [1 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Med, Dept Surg, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
[2] Univ Kebangsaan Malaysia, Fac Med, Dept Pathol, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia
关键词
Axillary node; metastasis; neuroendocrine tumor; tonsil; SMALL-CELL CARCINOMA; SURVIVAL; HEAD; NECK;
D O I
10.4103/jcrt.jcrt_1506_21
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
High-grade neuroendocrine carcinoma (NEC) of the tonsil is rare and has a poor prognosis. The usual presentation is a neck mass with locoregional cervical lymphadenopathy. An axillary lymphadenopathy as a primary presentation of NEC of the tonsils is uncommon and challenging to treat. Tonsil neuroendocrine tumors display aggressive behaviors associated with early recurrence and metastasis after surgical resection. Managing this condition is demanding compared to NECs of gastrointestinal origin since, to date, the management of head-and-neck neuroendocrine tumors is still not well established. We present a 49-year-old female with a rare case of NEC of the tonsil presenting primarily with axillary lymph nodes metastasis. The patient's axillary lymph node was biopsied and revealed a Grade III neuroendocrine tumor. A positron emission tomography (PET) scan was done in searching of a primary lesion and showed a highly metabolic mass of the left tonsil as well as a left axillary lymph node suggestive of metastasis. The patient has been managed with a multimodality approach, with a combination of chemotherapy regimen and surgical resection of the axillary lymph node. Subsequent PET scan evaluation showed a complete response of the primary tumor with residual left axillary lymph node metastasis. NECs of tonsil presented with axillary lymph nodes metastasis is rare and has a poor prognostic outcome. It poses a dilemma with regard to management, as surgical resection of the metastasis is not promising given the possibility of early recurrence.
引用
收藏
页码:2104 / 2107
页数:4
相关论文
共 50 条
  • [2] Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma
    Wang, Wenmiao
    Yuan, Peng
    Wang, Jiayu
    Ma, Fei
    Zhang, Pin
    Li, Qing
    TUMORI JOURNAL, 2014, 100 (06): : 600 - 604
  • [3] Unilateral axillary lymph node metastasis from small cell neuroendocrine carcinoma of the urinary bladder
    Mitra, Suvradeep
    Purkait, Suvendu
    Das, Manoj Kumar
    CYTOPATHOLOGY, 2021, 32 (03) : 371 - 373
  • [4] Axillary Lymph Node Metastasis in Ductal Carcinoma In Situ
    Ching, Karen
    Tartter, Paul
    Boachie-Adjei, Kwadwo
    Smith, Sharon Rosenbaum
    Estabrook, Alison
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : 31 - 31
  • [5] OBSCURE AXILLARY LYMPH NODE METASTASIS IN CARCINOMA OF THE BREAST
    SAPHIR, O
    AMROMIN, GD
    AMERICAN JOURNAL OF PATHOLOGY, 1948, 24 (03): : 726 - 727
  • [6] Secretory breast carcinoma presented with metastatic axillary lymph node
    Demiroz, Abu Senem
    Aydin, Ovgu
    Ilvan, Sennur
    Calay, Zerrin
    Ertem, Metin
    VIRCHOWS ARCHIV, 2007, 451 (02) : 298 - 298
  • [7] Neuroendocrine carcinoma of the prostate with metastases to axillary lymph node and bone
    Ciolino, Allison
    Trainer, Thomas
    Kida, Masatoshi
    MODERN PATHOLOGY, 2006, 19 : 79 - 79
  • [8] The presentation of contralateral axillary lymph node metastases from breast carcinoma: A clinical management dilemma
    Huston, Tara L.
    Pressman, Peter I.
    Moore, Anne
    Vahdat, Linda
    Hoda, Syed A.
    Kato, Meredith
    Weinstein, Douglas
    Tousimis, Eleni
    BREAST JOURNAL, 2007, 13 (02): : 158 - 164
  • [9] Metastasis in an axillary lymph node in hepatocellular carcinoma: a case report
    Alison, MR
    Leiman, G
    Kew, MC
    WORLD JOURNAL OF GASTROENTEROLOGY, 2000, 6 (05) : 770 - 772
  • [10] OBSCURE AXILLARY LYMPH-NODE METASTASIS IN CARCINOMA OF THE BREAST
    SAPHIR, O
    AMROMIN, GD
    CANCER, 1948, 1 (02) : 238 - 241